Florame USA
This article was originally published in The Rose Sheet
Executive Summary
French organic beauty company says it will undergo phased expansion in the U.S. personal care market. According to Chief Operating Officer Alain Berthelot, the company will take a "personal approach" to building the brand and capitalizing on U.S. consumers' growing interest in organic personal care, employing grassroots tactics to grow its retail, Internet and wholesale presence first in Texas and later across the U.S. The 16-year-old maker of certified organic eaux de toilettes and skin-, body- and hair-care products opened its first U.S. retail location in San Antonio, Texas in Sept. 2006. San Antonio is the "ideal location" for its first store, the firm maintains, noting that the city is not only one of the fastest growing in the nation but also home to a large Hispanic population, a consumer base found to be more interested in organic products than the general population, according to Florame USA...
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.